Acucela Appoints Executive VP, Legal Affairs
This article was originally published in Scrip
Acucela Inc., a clinical-stage biotechnology company developing novel drug candidates to treat and slow the progression of sight-threatening ophthalmic diseases, has hired Dr. George Lasezkay as executive vice-president of legal affairs – effective from Aug. 24. Lasezkay will head up Acucela's legal team and be the primary legal advisor to CEO Ryo Kubota and the rest of the executive team. He will also actively contribute to the development and execution of corporate alliance strategy at the company. Most recently, Lasezkay was president at HorizonPharma Group, a consultancy practice that advises life sciences companies on corporate strategy and business development.